Invitae Completes $117 Million Initial Public Offering

San Francisco – February 25, 2015 – Cooley advised the underwriters on Invitae Corporation's $116.8 million initial public offering. Invitae's mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. The company now trades on The New York Stock Exchange under the symbol "NVTA."

J.P. Morgan Securities LLC acted as the sole book-running manager for the offering. Cowen and Company, LLC and Leerink Partners LLC acted as co-managers.

The Cooley corporate securities team representing the underwriters included partners Charlie Kim, Dave Peinsipp and Drew Williamson and associates Kristin VanderPas, Eric Cheng, Dani Nazemian and Susan Walker.

Critical support for the offering was provided by partners Natasha Leskovsek and Wendy Goldstein, special counsel Phil Mitchell and associate Jennifer Shanley (health care and life sciences regulatory); partner Bill Christiansen (intellectual property); partner Susan Cooper Philpot (tax); and special counsel Laura McDaniels (compensation and benefits).

About Cooley LLP

Cooley's lawyers solve legal issues for entrepreneurs, investors, financial institutions and established companies. Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, often where innovation meets the law.
 

Cooley has 850 lawyers across 12 offices in the United States, China and Europe.

Related Contacts
Susan Cooper Philpot Retired Partner, San Francisco
David Peinsipp Partner, San Francisco
Charlie Kim Partner, San Diego
Natasha Leskovsek Partner, Washington, DC
Bill Christiansen Partner, Seattle
Kristin VanderPas Partner, San Francisco
Drew Williamson Partner, San Francisco
Wendy Goldstein Partner, New York
Phil Mitchell Partner, New York
Dani Nazemian Associate, San Diego